More about

Major Depressive Disorder

News
October 03, 2019
2 min read
Save

Ten drug combinations in major depressive disorder

Ten drug combinations in major depressive disorder

SAN DIEGO — Alternatives with new mechanisms of action are needed after 50 years of drug development focusing on monoamines for treating major depressive disorder, according to a session presented at Psych Congress.

News
October 03, 2019
1 min read
Save

Janssen submits supplemental new drug application for Spravato

Janssen submits supplemental new drug application for Spravato

The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a supplemental new drug application to the FDA seeking a new indication for Spravato CIII nasal spray for the rapid reduction of depressive symptoms in adults with major depressive disorder who have active suicidal ideation with intent.

News
October 01, 2019
1 min read
Save

5 stories to read for Depression Awareness Month

5 stories to read for Depression Awareness Month

More than 17 million adults in the U.S. have experienced a major depressive episode, according to data from the 2017 National Survey on Drug Use and Health.

News
September 25, 2019
2 min read
Save

Psychotic experiences linked to risk for several mental disorders

Findings from a large genome-wide association study indicated that genetic liability of psychotic experiences may be shared with several psychiatric disorders in addition to schizophrenia, including major depressive disorder, bipolar disorder and neurodevelopmental disorders.

News
September 16, 2019
1 min read
Save

National survey reveals glaucoma impacts patients, care givers

Glaucoma impacts patients and care givers significantly, according to a national survey conducted by the Glaucoma Research Foundation and supported by Aerie Pharmaceuticals.

News
September 09, 2019
2 min read
Save

Seltorexant shows antidepressant effect in MDD

Treatment with seltorexant improved depressive symptoms compared with placebo and the antidepressant efficacy was maintained for a month, according to be exploratory findings published in Translational Psychiatry.

News
August 28, 2019
2 min read
Save

Heightened impulsivity common in many psychiatric disorders

Results from a meta-analysis published in JAMA Psychiatry support delay discounting — a type of decision-making tied to impulsivity — as a robust transdiagnostic process across many different psychiatric disorders.

News
August 26, 2019
2 min read
Save

Cognitive deficits persist into remission of major depressive episodes

Depression-related cognitive deficits in selective attention, working memory and long-term memory persisted into remission from a major depressive episode and worsened with repeated episodes, study findings published in Lancet Psychiatry revealed.

News
August 21, 2019
2 min read
Save

Environmental pollution tied to increased risk for psychiatric disorders

Environmental pollution tied to increased risk for psychiatric disorders

Study findings published in PLOS Biology indicated that air pollution was significantly linked to increased risk for psychiatric disorders in the United States and Denmark.

News
August 20, 2019
2 min read
Save

Olanzapine may benefit patients with psychotic depression in remission

Continuing sertraline plus olanzapine compared with sertraline plus placebo reduced the risk for relapse over 36 weeks among adults with psychotic depression in remission, study findings published in JAMA showed.

View more